| Amount | Holding |
|---|---|
| 4.14% | Sony Corp ADR |
| 3.39% | Splunk Inc |
| 3.38% | Micron Technology Inc |
| 3.37% | Seattle Genetics Inc |
| 3.35% | Biogen Inc |
| 2.67% | Nektar Therapeutics |
| 2.51% | MarketAxess Holdings Inc |
| 2.37% | Eli Lilly and Co |
| 2.21% | Abiomed Inc |
| 2.19% | Biomarin Pharmaceutical Inc |
| 2.08% | Alibaba Group Holding Ltd ADR |
| 1.93% | Qiagen NV |
| 1.88% | Insulet Corp |
| 1.81% | Sprint Corp Registered Shs Series -1- |
| 1.74% | Universal Display Corp |
| 1.70% | Xencor Inc |
| 1.67% | Epizyme Inc |
| 1.57% | Tesla Inc |
| 1.57% | Adobe Inc |
| 1.57% | Chegg Inc |
| 1.50% | Delta Air Lines Inc |
| 1.49% | KLA Corp |
| 1.35% | Qualcomm Inc |
| 1.28% | United Airlines Holdings Inc |
| 1.28% | American Airlines Group Inc |
Expense Ratio Rating
9 /10
Expense Rating
4 /10
Market Score
9 /10
Category Score
5 /10
Market Size
9 /10
$POAGX Alternatives
71%
FI Score
- poagx
- Mutual Fund
- US Stocks
- Mid-Cap Growth
PRIMECAP Odyssey Aggressive Growth Fund
Expenses: 0.63% (Better than 1% of similar funds)
This is an OK choice for a Mid-Cap Growth US Stocks fund. See why ยป